The Science: Bradykinin, C1-INH, and Genetics
At a Glance
Hereditary Angioedema (HAE) Type 1 is caused by a SERPING1 gene mutation resulting in low levels of the C1-INH protein. This deficiency causes an overproduction of bradykinin, leading to severe swelling. Diagnosis is confirmed through lab tests showing low C4 and low C1-INH levels.
To understand Hereditary Angioedema (HAE) Type 1, you have to look at the microscopic “dam” that protects your blood vessels. This condition is not just a random symptom; it is a precisely understood biological event caused by a defect in your genetic code.
The Genetic Blueprint: SERPING1
Every cell in your body follows a set of instructions called the SERPING1 gene [1][2]. This gene’s job is to produce a protein called C1-esterase inhibitor (or C1-INH) [1].
In HAE Type 1, a mutation in this gene acts as a “stop” command, meaning your body simply does not produce enough of the C1-INH protein [3][4]. This is known as a quantitative deficiency [3]. In contrast, HAE Type 2 occurs when the body produces a normal amount of the protein, but the protein itself is “broken” and cannot do its job [5][6].
While HAE is an autosomal dominant condition—meaning a parent with the condition has a 50% chance of passing it to their child—you do not necessarily have to inherit it to have it. Approximately 25% of all HAE cases are de novo mutations [2][1]. This means the genetic change happened spontaneously in you, and you are the first person in your family to have it. This perfectly normal occurrence explains why many patients are confused by a “hereditary” diagnosis when no one else in their family shares their symptoms.
How the “Dam” Breaks: The Bradykinin Flood
The C1-INH protein acts like a dam in a complex system called the Contact Activation System [7]. Its job is to hold back several “chainsaw-like” proteins, most notably Plasma Kallikrein [7][8].
When you don’t have enough C1-INH (the dam), Plasma Kallikrein becomes overactive. It begins cutting into another protein to release a small but powerful messenger called bradykinin [9][10].
- The Signal: Bradykinin travels to the lining of your blood vessels (the endothelium) and binds to B2 receptors [9][11].
- The Leak: This binding signal tells the blood vessel cells to shrink and pull apart, creating microscopic gaps.
- The Swelling: Fluid from your blood leaks through these gaps into your skin or organ tissues, which creates the deep, painful swelling you feel during an attack [11][12].
Deciphering Your Lab Report
Doctors use three primary tests to confirm a diagnosis of HAE Type 1. Understanding these numbers can help you track your condition.
- C4 Level (Screening): This is the most common screening tool. Because the “dam” is broken, your body constantly uses up a protein called C4. In almost all HAE cases, your C4 levels will be consistently low, even between attacks [6][13].
- C1-INH Antigenic (Quantity): This test measures the physical amount of the C1-INH protein in your blood. In HAE Type 1, this value is low [5][14].
- C1-INH Functional (Quality): This test measures how well the protein is working. In HAE Type 1, this is also low because there isn’t enough protein to do the work [4][6].
Pathophysiology Table
Understanding the specific differences in how your body compares to other types of angioedema:
| Laboratory Marker | Normal Range | HAE Type 1 | HAE Type 2 |
|---|---|---|---|
| C4 Level | Normal | Low [6] | Low [13] |
| C1-INH Antigenic | Normal | Low [5] | Normal or High [14] |
| C1-INH Functional | Normal | Low [4] | Low [6] |
Genetic understanding is not just vital for your own care, but for the health of your family as well. Let your family know about your diagnosis so they can be appropriately screened.
Common questions in this guide
What causes Hereditary Angioedema Type 1?
Can I have HAE if no one else in my family has it?
What do low C4 levels mean on my HAE lab report?
What is the difference between HAE Type 1 and Type 2?
Should my family members be tested for HAE?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.In my case, what is the exact SERPING1 mutation, and should we consider genetic counseling for my family?
- 2.If my C4 levels were low but my C1-INH levels were borderline, should we repeat the testing during an active attack to confirm?
- 3.Are there any other markers, like C1q, that you used to distinguish this from Acquired Angioedema?
- 4.Since I have Type 1 (low concentration), does this change which medications are most effective for me compared to someone with Type 2?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE.
Drouet C, López-Lera A, Ghannam A, et al.
Frontiers in allergy 2022; (3()):835503 doi:10.3389/falgy.2022.835503.
PMID: 35958943 - 2
Recessive SERPING1 Variant Leads to Kinin-Kallikrein System Control Failure in a Consanguineous Brazilian Family with Hereditary Angioedema.
Maia LSM, Burger B, Ghannam A, et al.
Journal of clinical medicine 2023; (12(23)) doi:10.3390/jcm12237299.
PMID: 38068351 - 3
Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report.
Ushio Y, Wakiya R, Kameda T, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):84 doi:10.1186/s13223-022-00725-8.
PMID: 36117202 - 4
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ, Zanichelli A, Caballero T, et al.
Clinical and experimental immunology 2017; (188(1)):148-153 doi:10.1111/cei.12910.
PMID: 27936514 - 5
Hereditary angioedema (HAE) in children and adolescents: New treatment options.
Fasshauer M, Wedi B
Allergologie select 2024; (8()):336-345 doi:10.5414/ALX02532E.
PMID: 39502954 - 6
Screening for type II hereditary angioedema-the "poor man's c1-inhibitor function".
Jindal AK, Chiang V, Barman P, et al.
The journal of allergy and clinical immunology. Global 2024; (3(1)):100179 doi:10.1016/j.jacig.2023.100179.
PMID: 38026504 - 7
Medical algorithm: Management of C1 inhibitor hereditary angioedema.
Caballero T, Cabañas R, Pedrosa M
Allergy 2022; (77(3)):1060-1063 doi:10.1111/all.15115.
PMID: 34587298 - 8
A review of kallikrein inhibitor lanadelumab in hereditary angioedema.
Hwang G, Johri A, Ng S, Craig T
Immunotherapy 2019; (11(11)):937-944 doi:10.2217/imt-2018-0197.
PMID: 31234673 - 9
The future of therapeutic options for hereditary angioedema.
Smith TD, Riedl MA
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(4)):380-390 doi:10.1016/j.anai.2024.04.029.
PMID: 38679158 - 10
Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
Guo Y, Zhang H, Lai H, et al.
Orphanet journal of rare diseases 2022; (17(1)):399 doi:10.1186/s13023-022-02536-x.
PMID: 36324138 - 11
Bradykinin Metabolism and Drug-Induced Angioedema.
Smolinska S, Antolín-Amérigo D, Popescu FD
International journal of molecular sciences 2023; (24(14)) doi:10.3390/ijms241411649.
PMID: 37511409 - 12
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.
Gomez-Gutierrez P, Perez JJ
International journal of molecular sciences 2020; (22(1)) doi:10.3390/ijms22010257.
PMID: 33383825 - 13
The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
Stepaniuk P, Bosonea AM, Pourshahnazari P, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2021; (17(1)):103 doi:10.1186/s13223-021-00607-5.
PMID: 34627363 - 14
HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL, Christiansen SC
Clinical reviews in allergy & immunology 2016; (51(2)):216-29 doi:10.1007/s12016-016-8561-8.
PMID: 27459852
This page explains the genetics and laboratory testing for HAE Type 1 for educational purposes only. Always consult your immunologist or genetic counselor for interpreting your specific lab results or family screening needs.
Get notified when new evidence is published on Hereditary angioedema type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.